Sort
39,280 grants matching “leukemia”
Hemopexin as an Early Biomarker of Anthracycline Cardiac Toxicity
$646,527Aarti Asnani · Beth Israel Deaconess Medical Center · R01 · FY2025 · HL
Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
$646,503Eric Jessen Chow · Fred Hutchinson Cancer Research Center · R01 · FY2018 · CA
Single-Cell Methods for Analysis of Clonal Heterogeneity and Evolution in Cancer
$646,486Jerald P Radich · Fred Hutchinson Cancer Research Center · R01 · FY2013 · CA
Occupational Exposure Assessment
$646,414Melissa Friesen · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA
Novel targeted therapy for treating Ovarian Cancer
$646,388Ratna K Vadlamudi · University Of Texas Hlth Science Center · R01 · FY2023 · CA
Computational Tools For Bioinformatics And Genome Analysis
$646,228John I Powell · Center For Information Technology · Z01 · FY2008 · CT
Adrenergic modulation of cellular immune functions in CAR T cell-induced cytokine release syndrome
$646,181Verena Staedtke · Johns Hopkins University · U01 · FY2020 · CA
Targeting RAS in Pediatric Cancer
$646,143Marielle Yohe · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Research and Development of Effective Therapies for Patients with Rare Tumors
$646,140Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2019 · CA
Endothelial Regeneration Following Lung Vascular Injury
$646,129Asrar B. Malik · University Of Illinois At Chicago · R01 · FY2017 · HL
Interrogating the minor spliceosome to understand and treat leukemia
$646,044Omar Abdel-Wahab · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Interrogating the minor spliceosome to understand and treat leukemia
$646,044Omar Abdel-Wahab · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Advanced Imaging Tools to Assess Cancer Therapeutics in Pediatric
$645,998Heike Elizabeth Daldrup-Link · Stanford University · R01 · FY2022 · CA
Targeting neuronal transport to ameliorate vincristine neurotoxicity
$645,896Shuiying Hu · Ohio State University · R01 · FY2023 · CA
CORE II - Genetics & Informatics Using Statistics CORE (GENIUS)
$645,662Nancy J. Cox · University Of Chicago · U01 · FY2011 · GM
Rac GTPases as targets in lymphomagenesis
$645,498Yi Zheng · Cincinnati Childrens Hosp Med Ctr · R01 · FY2009 · CA
Mechanistic Insight to Predict and Prevent Nilotinib-Induced Artery Disease
$645,460Paul W. Burridge · Northwestern University At Chicago · R01 · FY2025 · CA
Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy
$645,363Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Targeting CDK6 expression/activity in Ph+ and Ph1-like acute lymphoblastic leukemia (ALL)
$645,339Bruno Calabretta · Thomas Jefferson University · R01 · FY2021 · CA
Brain Tumors - Immunological and Biological Studies
$645,238Darell D Bigner · Duke University · R37 · FY2006 · CA
A118G SNP and OPRM1 Gene Opioid-Mediated Effects in Humans
$645,205Kelly E Dunn · Johns Hopkins University · R01 · FY2015 · DA
Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease
$645,084Amy Klion · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Predictive Markers in Metastatic Renal Cancer
$644,954Frederic M. Waldman · University Of California, San Francisco · R01 · FY2009 · CA
New retroviral restriction factor
$644,871Tatyana V. Golovkina · University Of Chicago · R01 · FY2020 · AI
Clinical Trials with Immunotoxins
$644,817Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA